Sanofi

BioNTech recruits rivals to boost Covid-19 vaccine production

Apple Inc. (NASDAQ: AAPL), Sanofi (NYSE: SNY) – Apple’s long-standing mixed reality headset to launch in 2022: analyst

Sanofi producing Johnson & Johnson COVID-19 vaccines

Sanofi will produce 12M vaccines per month for rival Johnson & Johnson

GSK and Sanofi start new Covid-19 vaccine trial after setback last year

Bristol-Myers, Sanofi ordered Hawaii to pay $ 834 million on the Plavix warning label

Bristol-Myers, Sanofi ordered Hawaii to pay $ 834 million on the Plavix warning label

Sanofi CEO: Vaccine candidate will not be ready in 2021

Sanofi’s COVID-19 mRNA candidate vaccine is not ready this year – CEO

Sanofi’s candidate COVID-19 mRNA vaccine is not ready this year, said the CEO

Sanofi’s candidate COVID-19 mRNA vaccine is not ready this year, said the CEO

EU promotion for vaccine supplies gets help from Bayer deal